Spectral AI Inc. (MDAI)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 2.06 |
Market Cap | 44.10M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.63 |
PE Ratio (ttm) | -3.29 |
Forward PE | n/a |
Analyst | Buy |
Ask | 2.08 |
Volume | 542,689 |
Avg. Volume (20D) | 2,487,535 |
Open | 1.97 |
Previous Close | 1.96 |
Day's Range | 1.96 - 2.10 |
52-Week Range | 0.82 - 3.72 |
Beta | undefined |
About MDAI
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. ...
Analyst Forecast
According to 3 analyst ratings, the average rating for MDAI stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 92.77% from the latest price.
Next Earnings Release
Analysts project revenue of $6.83M, reflecting a 29.18% YoY growth and earnings per share of -0.14, making a -36.36% decrease YoY.
Why Price Moved
News
2 months ago · seekingalpha.com
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call TranscriptSpectral AI, Inc. (NASDAQ:MDAI ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Devin Sullivan - MD of Equity Group Michael DiMaio - Chairman Vincent Capone - CFO Co...
2 months ago · proactiveinvestors.com
Spectral AI reports strong Q3 performance, reaffirms FDA submission timelineSpectral AI Inc (NASDAQ:MDAI) reported a strong financial performance for the third quarter of 2024, highlighted by a 138% increase in research and development revenue as it advanced its burn wound te...
2 months ago · proactiveinvestors.com
Spectral AI to spin off subsidiary to focus on IP monetization, healthcare AI expansionSpectral AI Inc (NASDAQ:MDAI) announced plans to spin off its subsidiary, Spectral IP, Inc., through a deal with Sauvegarder Investment Management, Inc. (SIM). The transaction aims to position Spectra...
2 months ago · proactiveinvestors.com
Spectral AI moves closer to FDA filing for burn wound assessment deviceSpectral AI Inc (NASDAQ:MDAI) announced that the final group of patients at burn centers in its US Burn Pivotal Study have completed their clinical visits, with topline results expected in December 20...